Login / Signup

Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study.

Seyed Saman TalebiMehran GhasemiMaryam Etminani-EsfahaniYounes MohammadiRasool Haddadi
Published in: Pharmacological reports : PR (2022)
Taken together, L-carnitine can be considered as a drug supplement in patients with COVID-19.
Keyphrases
  • coronavirus disease
  • sars cov
  • adverse drug
  • respiratory syndrome coronavirus